Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 143
Filter
1.
Clin Exp Rheumatol ; 27(5): 773-8, 2009.
Article in English | MEDLINE | ID: mdl-19917159

ABSTRACT

OBJECTIVE: To investigate the role of sTREM-1 and PTX3 as markers of infection in febrile patients with SLE. METHODS: In febrile (body temperature > or =38 degrees C) patients with SLE, blood samples of day 0, 1, 2, and 14 after presentation were drawn and relevant clinical data were collected. The patients were allocated to an infection group (n=19) or disease flare group (n=14). Serum levels of sTREM-1 and PTX3 were measured by ELISA using the serum samples of SLE patients and age- and sex-matched healthy controls (n=31). RESULTS: A total of 33 febrile episodes occurred in 32 SLE patients (19 infections, 14 flares) were studied. sTREM-1 levels on day 0 were significantly higher in the infection group than in the flare group (109.9 pg/ml (median) vs. 48.0 pg/ml, p=0.002), but PTX3 levels were similar in these two groups. The difference of sTREM-1 levels between infection group and flare group was persistent on day 1 and 2 (day 1, p=0.007; day 2, p=0.034). The highest diagnostic value (sensitivity=1.0, specificity=0.664) of sTREM-1 was obtained at the threshold value of 53.2 pg/mL. CONCLUSION: Serum sTREM-1 levels were significantly higher in the infection group than in the flare group of febrile SLE patients. Our findings suggest that serum sTREM-1 levels could be used to determine whether SLE patients have contracted an infection.


Subject(s)
C-Reactive Protein/analysis , Infections/blood , Infections/complications , Lupus Erythematosus, Systemic/blood , Lupus Erythematosus, Systemic/complications , Membrane Glycoproteins/blood , Receptors, Immunologic/blood , Serum Amyloid P-Component/analysis , Adolescent , Adult , Aged , Biomarkers/blood , Case-Control Studies , Female , Fever/blood , Fever/etiology , Humans , Male , Middle Aged , ROC Curve , Triggering Receptor Expressed on Myeloid Cells-1 , Young Adult
2.
Clin Exp Dermatol ; 34(8): e737-9, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19663848

ABSTRACT

We describe an infant with a congenital polypoid anal mass, diagnosed as botryoid-type embryonal rhabdomyosarcoma. Histological examination revealed myxoma-like appearance and cells with greater differentiation with elongated streaming eosinophilic cytoplasm and one or two nuclei, suggestive of rhabdomyoblasts. Tumour cells were strongly immunoreactive for desmin and 10% of cells displayed immunoreactivity for myoglobin. We present this case with a view to highlighting the benign clinical and histological appearance of botryoid-type embryonal rhabdomyosarcoma. Early biopsy is essential for improving prognosis.


Subject(s)
Anus Neoplasms/pathology , Rhabdomyosarcoma, Embryonal/pathology , Anus Neoplasms/congenital , Anus Neoplasms/drug therapy , Desmin/analysis , Early Detection of Cancer , Humans , Infant , Male , Neoplasm Proteins/analysis , Prognosis , Rhabdomyosarcoma, Embryonal/drug therapy
3.
Clin Exp Dermatol ; 34(5): e18-20, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19486038

ABSTRACT

Dermatofibroma (DF) is a common benign fibrohistiocytic tumour with a predilection for the legs in middle-aged women. Giant DF, a rare clinical variant of DF, is characterized by its unusually large size. Granular cell change is typical of granular cell tumour, but can be observed in diverse cell lineages. Traumatic factors may be involved in the pathogenesis of giant DF and cellular granularity. We describe a 49-year-old Korean man with a giant DF showing granular cell differentiation, which may have been caused in part by multiple treatments with bee-venom acupuncture.


Subject(s)
Acupuncture Therapy/adverse effects , Bee Venoms/adverse effects , Histiocytoma, Benign Fibrous/etiology , Skin Neoplasms/etiology , Biopsy , Histiocytoma, Benign Fibrous/pathology , Humans , Male , Middle Aged , Skin Neoplasms/pathology
4.
Br J Dermatol ; 161(5): 1045-51, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19558553

ABSTRACT

BACKGROUND: The multitargeted kinase inhibitors sorafenib and sunitinib have improved treatment of solid tumours including renal cell carcinoma and hepatocellular carcinoma by offering better clinical responses. However, sorafenib and sunitinib are commonly associated with cutaneous toxicity. OBJECTIVES: We conducted this study to make a clinical assessment of the cutaneous toxicities induced by the oral multitargeted kinase inhibitors sorafenib and sunitinib. METHODS: Retrospectively, we reviewed medical records of patients receiving multitargeted kinase inhibitors, including 109 patients on sorafenib for the treatment of renal cell carcinoma or hepatocellular carcinoma and 119 patients receiving sunitinib for treatment of renal cell carcinoma or a gastrointestinal stromal tumour. Clinical data on cutaneous toxicities were collated. We describe the incidences and intensities of toxicities, and analyse the data statistically. RESULTS: The most common cutaneous toxicity was hand-and-foot skin reaction (HFSR). Other cutaneous toxicities included alopecia, stomatitis, skin discoloration (hair or face), subungual splinter haemorrhage, facial swelling, facial erythema and xerosis. HFSR and severe stomatitis required therapy modifications to relieve symptoms, but other cutaneous toxicities did not affect treatment course. HFSR was observed in 48% of patients treated with sorafenib and 36% of those treated with sunitinib. Median time to onset was 18.4 days in patients receiving sorafenib and 32.4 days in those receiving sunitinib. HFSR and stomatitis were early symptoms compared with other cutaneous toxicities. Patients with severe HFSR were likely to develop the symptoms at early phases of therapy. A significant correlation between the severity of HFSR and development of alopecia and stomatitis was found. CONCLUSIONS: Multitargeted kinase inhibitors are associated with a significant risk of various cutaneous adverse events. HFSR is the commonest and most serious cutaneous toxicity in patients treated with these drugs.


Subject(s)
Benzenesulfonates/adverse effects , Drug Eruptions/etiology , Indoles/adverse effects , Protein Kinase Inhibitors/adverse effects , Pyridines/adverse effects , Pyrroles/adverse effects , Skin Diseases/chemically induced , Administration, Oral , Adult , Aged , Aged, 80 and over , Alopecia/chemically induced , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/adverse effects , Benzenesulfonates/administration & dosage , Carcinoma, Hepatocellular/drug therapy , Carcinoma, Renal Cell/drug therapy , Female , Foot Dermatoses/chemically induced , Gastrointestinal Stromal Tumors/drug therapy , Hand Dermatoses/chemically induced , Humans , Indoles/administration & dosage , Kidney Neoplasms/drug therapy , Male , Middle Aged , Niacinamide/analogs & derivatives , Phenylurea Compounds , Protein Kinase Inhibitors/administration & dosage , Pyridines/administration & dosage , Pyrroles/administration & dosage , Retrospective Studies , Skin Diseases/pathology , Sorafenib , Stomatitis/chemically induced , Sunitinib , Young Adult
10.
Clin Exp Dermatol ; 34(8): e869-72, 2009 Dec.
Article in English | MEDLINE | ID: mdl-20055851

ABSTRACT

Focal myositis (FM) is a benign localized inflammatory process of unknown aetiology, which presents as a rapidly enlarging soft-tissue mass that evolves into a localized lesion. It is most often mistaken for a neoplasm. Histologically, it is characterized by marked myopathic changes of the muscle fibres, lymphocytic infiltration and interstitial fibrosis. We describe a case of focal myositis of the tongue and review this rare condition.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Macroglossia/pathology , Myositis/pathology , Tongue/pathology , Diagnosis, Differential , Female , Humans , Macroglossia/drug therapy , Middle Aged , Myositis/drug therapy , Treatment Outcome
11.
Clin Exp Dermatol ; 34(5): e174-6, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19094134

ABSTRACT

The most common metastatic sites of cholangiocarcinoma are the retroperitoneal lymph nodes, peritoneum, liver and lungs, and cutaneous metastases of cholangiocarcinoma are rare. Although cutaneous metastases of internal malignancies most commonly present clinically as nontender nodules appearing in a particular area of body, other presentations can occur. Cutaneous metastases of cholangiocarcinoma can appear as a solitary tumour at the therapeutic drainage site. We report a 60-year-old man with unusual cutaneous metastases from hilar cholangiocarcinoma, which presented as multiple indurated plaques and papules on the anterior chest.


Subject(s)
Bile Duct Neoplasms , Bile Ducts, Intrahepatic , Cholangiocarcinoma/secondary , Skin Neoplasms/secondary , Aged , Biopsy , Cholangiocarcinoma/pathology , Female , Humans , Male , Middle Aged , Skin Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...